Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
190 JPY
4.12 B JPY
54.64 B JPY
11.75 M
About TORII PHARMACEUTICAL CO
Sector
CEO
Goichi Matsuda
Headquarters
Tokyo
Website
Founded
1872
ISIN
JP3635800000
FIGI
BBG000BCWSL0
Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. Its products are mainly used for renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases, and allergies. These include Riona, Remitch, Kayexalate, Corectim, Antebate, Cedarcure, and Miticure. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4551 is 4,665 JPY — it has decreased by −1.89% in the past 24 hours. Watch TORII PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TORII PHARMACEUTICAL CO stocks are traded under the ticker 4551.
4551 stock has risen by 5.66% compared to the previous week, the month change is a 19.01% rise, over the last year TORII PHARMACEUTICAL CO has showed a 29.58% increase.
We've gathered analysts' opinions on TORII PHARMACEUTICAL CO future price: according to them, 4551 price has a max estimate of 5,170.00 JPY and a min estimate of 3,800.00 JPY. Watch 4551 chart and read a more detailed TORII PHARMACEUTICAL CO stock forecast: see what analysts think of TORII PHARMACEUTICAL CO and suggest that you do with its stocks.
4551 reached its all-time high on Nov 15, 2024 with the price of 4,630 JPY, and its all-time low was 1,190 JPY and was reached on Oct 28, 2008. View more price dynamics on 4551 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4551 stock is 12.01% volatile and has beta coefficient of 0.47. Track TORII PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is TORII PHARMACEUTICAL CO there?
Today TORII PHARMACEUTICAL CO has the market capitalization of 133.67 B, it has increased by 4.39% over the last week.
Yes, you can track TORII PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
TORII PHARMACEUTICAL CO is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
4551 net income for the last quarter is 1.30 B JPY, while the quarter before that showed 1.34 B JPY of net income which accounts for −2.90% change. Track more TORII PHARMACEUTICAL CO financial stats to get the full picture.
TORII PHARMACEUTICAL CO dividend yield was 3.38% in 2023, and payout ratio reached 81.87%. The year before the numbers were 3.43% and 71.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 583.00 employees. See our rating of the largest employees — is TORII PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TORII PHARMACEUTICAL CO EBITDA is 6.91 B JPY, and current EBITDA margin is 9.65%. See more stats in TORII PHARMACEUTICAL CO financial statements.
Like other stocks, 4551 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TORII PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TORII PHARMACEUTICAL CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TORII PHARMACEUTICAL CO stock shows the strong buy signal. See more of TORII PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.